Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma-Reference-Cited by-同舟云学术

Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma

Published:2016-06 Issue:3 Volume:43 Page:304-308
ISSN:0385-8146
Container-title:Auris Nasus Larynx
language:en
Short-container-title:Auris Nasus Larynx

Author:

Yamaguchi Tomoko,Ishii Toyota,Yamamoto Kazuhiro,Higashi Noritaka,Taniguchi Masami,Okamoto Makito

Publisher

Elsevier BV

Subject

General Medicine,Otorhinolaryngology,Surgery

Reference21 articles.

1. Eosinophilic sinusitis;Haruna;JIBI INKOKA TEMBO,2001

2. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma;Steinke;J Allergy Clin Immunol,2003

3. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects;Nasser;Am J Respir Crit Care Med,1996

4. Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways;Sousa;Am J Respir Crit Care Med,1997

5. Leukotriene C4 elimination and metabolism in man;Maltby;J Allergy Clin Immunol,1990

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary Leukotriene E4 as a Biomarker in NSAID-Exacerbated Respiratory Disease (N-ERD): a Systematic Review and Meta-analysis;Current Allergy and Asthma Reports;2022-11-14

2. Inflammatory features and predictors for postsurgical outcomes in patients with nasal polyps stratified by local and systemic eosinophilia;International Forum of Allergy & Rhinology;2020-10-04

3. Expression of COX-1, COX-2, 5-LOX and $$\hbox {CysLT}_2$$ in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease;Allergy, Asthma & Clinical Immunology;2019-12

4. Are allergies, asthma or hypersensitivity to NSAIDs equally a risk factor for the development of a specific CRS phenotype?;Otolaryngologia Polska;2019-10-11

5. Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti‐inflammatory drug‐induced urticaria;Allergy;2019-02-06